Caren L. Freel Meyers
- Johns Hopkins University · Pharmacology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #17,437
- R01 Holder
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8548306Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#17,437
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Caren L. Freel Meyers as a PI. Multi-PI records show the full award amount for context.
- 5T32GM135083-07T32Contact PIPharmacology and Molecular Sciences Training ProgramJohns Hopkins University · Pharmacology (NIH department code)$487.5Kaward amount
- 2R01GM143810-05R01Contact PIToward Understanding the Chemistry and Biology of Microbial DXP SynthaseJohns Hopkins University · Pharmacology (NIH department code)$403.4Kaward amount
- 1R21AI193561-01A1R21Contact PIPan-DXPS probes for target development in pathogenic bacteriaJohns Hopkins University · Pharmacology (NIH department code)$233.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing Caren L. Freel Meyers as a PI.
FY2026 award administered by Johns Hopkins University (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardJohns Hopkins University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9941
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder